Clinical Trial Update: Chinese Arteriosclerosis Series Evaluation-She Minority Study

View source ↗

Summary

Clinical trial update on arteriosclerosis in the She Minority population in China, sponsored by Peking University Shougang Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriosclerosis

Snippet

Sponsor: Peking University Shougang Hospital | Conditions: Vascular Disease | Status: UNKNOWN